Akna Medical Pvt Ltd

Akna Medical Pvt Ltd, based in Bangalore, India, is a leading hospital-focused supply chain platform that enhances healthcare procurement through innovative cloud-based technology. Founded in 2018, Akna Medical Pvt Ltd specializes in optimizing procurement processes for hospitals across India. The company was co-founded by Mayank Kapoor, Saurabh Pandey, and Shaunak Joshi, with Saurabh Pandey currently serving as the CEO. Akna Medical has raised a total of USD 6,426.

91 mn through multiple funding rounds, with its latest round being an Add-on Trade Sale led by PharmEasy, amounting to USD 144. 00 mn on September 14, 2021. The company has executed a total of 5 deals to date. Aknamed operates as India's largest hospital-focused supply chain platform, primarily offering a cloud-based technology solution designed to streamline and enhance procurement and consumption in the healthcare sector.

The company’s core product offerings include SmartChain for companies and SmartBuy for hospitals, which collectively facilitate improved operational efficiency, consolidated procurement, and data-driven decision-making. Aknamed serves over 1,200 hospitals across India, providing a comprehensive product catalog that encompasses more than 45,000 medical consumables. The platform enhances visibility in inventory management, enabling real-time tracking of stock positions and optimizing procurement strategies, catering to multi-specialty hospital chains and healthcare manufacturers nationwide. In 2023, Akna Medical Pvt Ltd reported revenue of USD 142,905,130 with an EBITDA of USD -24,468,592, generated primarily through its B2B cloud-based supply chain management services.

Akna Medical Pvt Ltd aims to enhance its product offerings by developing new solutions for healthcare procurement aimed for release in the upcoming quarters. The company is also strategizing to expand its market presence into additional regions across India, with specific plans set for 2024. Recent funding from their latest round will be allocated to bolster these initiatives, enhancing product development and market penetration strategies.